ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences
9/4/2013 7:03:27 AM
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
•Morgan Stanley Global Healthcare Conference
9:10 am ET, September 11 in New York, NY
Help employers find you! Check out all the jobs and post your resume.